OBJECTIVE: Although there are changes in the postprandial lipid responses of obese patients, these are closely associated with high fasting triglycerides (TG). This study of 17 normotriglyceridemic, normoglucose-tolerant android obese subjects (body mass index, BMI 34.3 AE 3.1 kgam 2 ) and 33 normal-weight controls (BMI 21.8 AE 1.6 kgam 2 ) was done to examine their postprandial responses to an oral fat loading test containing retinol (890 calories, 85% fat) and to evaluate the possible association between clinical and biological features of obesity andaor insulin resistance and postprandial lipemia. SUBJECTS AND MEASUREMENTS: Blood samples were taken before giving the fat load and at 2,3,4,5,6 and 8 h after it. Insulin sensitivity was assessed using HOMA, and TG and retinyl palmitate (RP) in the plasma, chylomicrons and non-chylomicron fractions were measured each time. RESULTS: The areas under the curves (AUC) of chylomicron TG for the obese and controls were not different, indicating adequate lipolytic activity. By contrast, the AUC for non-chylomicron TG was signi®cantly greater in the obese than in the controls (512 AE 135 vs 429 AE 141 mmolal min, P`0.01). In addition, the AUC for RP in this same fraction was signi®cantly lower in the obese than in the controls (103 AE 55 vs 157 AE 88 mgal min, P`0.05), suggesting that the TG from endogenous lipoproteins accounted for most of the increase in TG in the non chylomicron fraction. Parameters related to obesity showed no relationship with these postprandial abnormalities, whereas HOMA, which discriminated between the groups, partly explained (r 2 23%, P`0.01) the signi®cant increase in non-chylomicron TG. CONCLUSIONS: Android obese patients with a fasting TG in the normal range and not different from the fasting TG of lean controls had an abnormal postprandial lipemia response, indicated by a signi®cantly greater TG in the nonchylomicron subfraction than in controls. These alterations may be partly due to postprandial changes in endogenous lipoproteins as a consequence of insulin resistance.
Introduction
Atherosclerosis is a major cause of morbidity and death in af¯uent countries and postprandial lipoprotein metabolism is likely to be involved in atherogenesis, as ®rst suggested by Zilversmit. 1 Several studies have described abnormalities in postprandial metabolism in patients with coronary artery disease, 2 ± 4 and shown that postprandial triglycerides (TG) are independent predictors of coronary artery disease in multivariate analysis, 5 even after adjustment for fasting TG or HDL-cholesterol in normolipidemic men. 6 Obesity is associated with abnormal fasting lipid parameters such as increased fasting triglyceride and decreased HDL-cholesterol, 7 which could explain, at least in part, the greater development of cardiovascular disease in obese people. Nevertheless, obesity appears to be an independent risk factor for coronary artery disease, even in subjects with normal fasting plasma lipids and normal glucose tolerance. 8 Some studies have reported altered postprandial lipemia in obese patients, 9 ,10 but little is known about postprandial lipid metabolism in normolipidemic and normoglucose tolerant obese patients.
Liver-derived triglyceride-rich lipoproteins have recently been suggested to be important in the postprandial lipemia alterations in patients with coronary heart disease. 11 In obese patients, these alterations could be due mainly to increased postprandial VLDL production 9, 10 or to a defect in the clearance of intestinal or hepatic TG-rich lipoproteins. 12 The decreased insulin sensitivity commonly associated with obesity 13 and the abdominal distribution of fat 14 may well play an important part. Some published reports indicate that hyperinsulinemia andaor decreased insulin sensitivity is involved in altered postprandial lipemia, 15 ± 17 while other authors found no association between an exaggerated postprandial TG response and the features of insulin resistance. 18 However, most of these studies were done on obese patients with dyslipidemia or with signi®cantly higher triglycerides than in controls (parameters known to in¯uence postprandial state, 9,16,19 ± 21 ) making it dif®-cult to evaluate the in¯uences of obesity and lipid parameters on postprandial lipemia. The impact of insulin resistance on postprandial metabolism remains to be analyzed independently of other parameters known to in¯uence postprandial metabolism.
Therefore, the present study was conducted on obese patients with normoglucose tolerance and normal fasting lipid concentrations that were not different from those of normal weight healthy controls to examine the postprandial response to an oral fat loading test and to evaluate the possible association between clinical and biological features of obesity andaor insulin resistance and postprandial lipemia.
Materials and methods

Patients and controls
A group of 17 obese patients (®ve men, 12 women) and 33 normal weight controls (21 men, 12 women) were recruited. All had a normal glucose tolerance (fasting plasma glucose (t 0 min )`6.1 mmolal and 2 hplasma glucose (t 120 min )`7.8 mmolal after an oral glucose tolerance test) and fasting lipid levels (triglyceride`1.70 mmolal, HDL-cholesterol b 0.90 mmolal for men, and 1.03 mmolal for women, and LDL-cholesterol`4.13 mmolal).
Android obese patients were selected according to the following criteria: (1) body mass index (BMI) was used as an index of adiposity, obesity was de®ned by a BMI above 30 kgam 2 ; (2) abdominal (android) fat distribution was de®ned by a waist-to-hip ratio (WHR) over 0.85 for women, and over 0.95 for men; (3) none of the patients was morbidly obese. Healthy subjects were selected according to the following criteria: BMI 18 ± 25 kgam 2 and stable body weight (less than 2% change in the last 3 months).
All the participants (obese and control) also had no symptoms of illness, no family history of premature coronary disease (before 60 y), and normal pro®les for blood creatinine, sodium, potassium, chloride, total protein, total and direct bilirubin, and aspartate (AST), alanine (ALT) amino-transferase, and gamma-glutamyl transferase (gGT) activities. None of them had any endocrine or gastrointestinal disease, renal failure, hypertension (systolic blood pressure`140 mmHg, diastolic blood pressure`90 mmHg), or was a regular smoker (cigarette smoking was de®ned as the consumption of more than 10 cigarettes daily for at least 5 y). The participants claimed to have stopped smoking 7 days before the study. None of the participants (obese or controls) was on any medication known to affect carbohydrate or lipoprotein metabolism, and their alcohol intake was limited (below 20 gaday). All the women were premenopausal (in follicular cycle) and none of them was taking oral contraceptive or hormone replacement therapy. This project was approved by the local Ethics Committee of the Nancy University Hospital (France) and all subjects gave their written informed consent.
Dietary assessments
A 7-day dietary record, including a week-end and 5 weekdays, was used to determine the subjects usual energy intakes and proportion of fats, carbohydrates and proteins. A weight maintenance diet was prescribed for all subjects (50% carbohydrate, 33% fat (PaS ratio 80%) and 17% protein) for the 7 days before the study to ensure uniformity.
Three days prior to the oral fat load test (OFLT), they were instructed to maintain their usual level of activity and to refrain from any strenuous exercise, to limit the in¯uence of acute exercise, which alters lipid metabolism. 22, 23 For the same reason, alcohol was not allowed during the 3 days immediately prior to OFLT. 24, 25 The day before the fat load test, controls and obese patients were admitted at 20:00 h to the Clinical Research Center for a calibrated meal corresponding to step 1 of the National Cholesterol Education Program 26 (690 calories, with 31% fat, 19% protein and 50% carbohydrate). They remained fasted for 12 h until 08:00 h, when the oral fat load was given.
Oral fat load test
The fat load consisted of 180 g of a blended emulsi®ed meal containing 3.5% dry skimmed milk, 19.25% butter, 23.75% peanut oil, 22% chocolate, 30.25% water, 0.75% gelatin, 0.25% sorbic acid and 0.25% potassium sorbate (Laboratoires Pierre Fabre Sante Â, Castres, France). It provided 890 calories (85% fat, 13% carbohydrates, 2% protein) and contained 88 mg cholesterol, 35 g saturated fatty acid, 30 g mono-and 15 g poly-unsaturated fatty acid. The fatty acid composition of the OFLT was determined by gas chromatography. The OFLT contained 1.25% of the total fatty acids as 10:0, 1.5% as 12:0, 3.1% as 14:0, 20.3% as 16:0, 12.3% as 18:0, 43.7% as 18:1, 13.3% as 18:2 and 1.08% as 20:0. Oral vitamin A (100,000 Ul retinyl ester) was added to the fat load (Avibon 1 50 000 Ul Theraplix, Rhone Poulenc Rorer, Paris, France) and was used to label intestinally derived lipoproteins. The fat load was ingested in 15 min, with 200 mL water. No further food or drink were allowed during the study period. The participants were instructed to remain in bed, in a supine position.
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Laboratory procedures
Total cholesterol and triglycerides were measured enzymatically (bioMe Ârieux, Marcy l'Etoile, France). HDL-cholesterol was assessed by phosphotungstic acid precipitation and LDL-cholesterol was calculated according to the Friedewald formula. 27 HDL2-and HDL3-cholesterol concentrations were determined by nondenaturating electrophoresis in discontinuous-gradient gels. 28 Apo Al and apoB were determined by immuno-nephelometry with commercial kits (Beckman, Gagny, France). Free fatty acids (FFA) were measured by enzymatic assay using Wako kits (Unipath, Dardilly, France). Plasma glucose was determined enzymatically (bioMe Ârieux, PAP 250, Marcy l'Etoile, France). Total plasma insulin concentration was determined by immuno-enzymatic assay (Insulin IMX 1 , Abbott Laboratories, Tokyo, Japan). Crossreactivity with pro-insulin was below 0.05%
Retinyl palmitate (RP) was measured by reversephase high performance liquid chromatography (System Gold, Beckman), according to De Ruyter et al. 29 The detection limit was 0.018 mgal. Although we recognize the limitations of retinyl esters as speci®c markers of chylomicrons and chylomicron remnants, 30 ,31 the RP levels serve as useful estimates of the intestinally derived component of postprandial lipemia. 32 The apo E genotypes were determined using Hha l restriction enzyme and the polymerase chain reaction (PCR). 33 Fasting plasma leptin concentrations were measured in triplicate by radioimmunoassay (Kit, LINCO Research Inc. St Louis, MO, USA). The intra-assay and inter-assay coef®cients of variation were 4.5% and 8%, respectively.
Insulin sensitivity was assessed from blood samples collected 30, 20 and 10 min before the ingestion of the oral fat load using the homeostasis model assessment (HOMA) system described by Matthews et al 34 with the formula (insulin mUal Â plasma glucose mmola l)a 22.5.
Collection of sequential blood samples
A 21 gauge venous canula was inserted into an antecubital vein 30 min prior to the fat load. Blood samples were then taken, 30,20 and 10 min before the fat load and 2,3,4,5,6 and 8 h later (T0, T2, T3, T4, T5, T6 and T8). Plasma glucose and insulin concentrations were assessed at T0 and T2. The apo E genotype, apo Al and apo B, plasma total LDL-and HDL-cholesterol, HDL2-and HDL3-cholesterol concentrations were determined to T0. Samples (15 ml) of blood were collected in vacutainer tubes at all times from T0 to T8. The tubes contained a ®nal concentration of 0.15% EDTA for measuring TG in the plasma, chylomicron and non-chylomicron fractions, and RP in the plasma and non-chylomicron fraction. All blood samples were immediately centrifuged at 1000g for 15 min, at 4 C. Phenylmethylsulfonyl¯uoride (10 mmolal, dissolved in isopropanolol) and aprotinin (Trasylol 1 , Bayer Pharma, Puteaux, France) were immediately added to the plasma to ®nal concentrations of 10 and 28 mmolal, respectively. A lipoprotein fraction (supernatant) containing predominantly chylomicrons (Svedberg¯otation, Sf b 400) was isolated by ultracentrifugation for 30 min at 25,000 rpm (100,000g) in a Beckman XL-80 ultracentrifuge, rotor Ti-SW 41 (Palo Alto, CA, USA). The infranatant was collected and named the non-chylomicron fraction (Svedberg¯otation, Sf`400), which contained triglyceride-rich lipoproteins (chylomicron remnants, very low density lipoproteins (VLDL) and VLDL remnants). Mean recovery ( AE s.d.) was 98 AE 3% for TG. Triglycerides in the plasma and fractions were assayed the same day and aliquots of plasma and nonchylomicron fraction were stored at À80 C until assayed for RP. The RP content of the chylomicron fraction was calculated as the difference between total plasma and non-chylomicron RP.
Statistical analysis
Data are meansAE s.d. When the distribution of a variable was not normal, as assessed by skewness and kurtosis tests, data were log-transformed, and statistical analysis was performed on the log-transformed data. The chi-squared test was used to compare the distributions of apoE genotype in the obese and control groups. The areas under the time concentration curves (area under curves: AUCs) were calculated by the trapezoidal method. 35 Incremental AUC (AUCi) was evaluated after subtracting the initial individual values (T0) for triglyceride from all respective postprandial measurements, yielding the net postprandial change.
Repeated-mesasures ANOVA was used to assess the differences in the postprandial TG and RP concentrations between groups. When ANOVA was signi®cant, or when variables were measured only once, means were compared between groups by Student's unpaired t-test. Data were compared by the Mann ± Whitney U-test for two matched groups, or when men and women were analyzed separately. A regression test was used to test univariate correlations between continuous variables. Analysis of covariance was performed to de®ne signi®cant variables to be included into the models of stepwise regression analysis. Non-Gaussian variables were log transformed before multiple linear regression analysis to identify signi®cant independent predictors of postprandial lipemia parameters. Signi®cance was implied at P`0.05. StatView 1 software (Abacus Concepts Inc., StatView V, Brain Power, Calabasas, CA) was used for all calculations.
Results
Characteristics and lipid concentrations of obese patients and controls
The clinical and biological characteristics of the obese patients and controls, men and women separately, are shown in Table 1 . As expected, the body weight, waist circumference and waist-to-hip ratio of men were higher than for women in each group. Leptin concentrations were signi®cantly (4-fold) elevated in obese patients, and leptin levels were higher in women than in men in each group. HOMA levels were higher in obese men and obese women than in controls. The fasting lipid and lipoprotein concentrations are shown in Table 2 . Triglyceride concentrations remained within the normal range, although they were slightly but not signi®cantly higher in the obese than in controls. Although HDL-cholesterol was in the normal range (according to the selection criteria), HDL and HDL2-cholesterol levels were signi®cantly lower in obese patients than in controls (P`0.05 and 0.01). HDL2 levels were lowest in obese men and signi®cantly lower than in obese women (P`0.05).
The distributions of apo E isoforms between obese and controls were similar. No subject was homozygous for the apo E2 isoform.
Postprandial lipid responses in obese patients and controls
The OFLT was well-tolerated. No subject suffered from nausea or reported any adverse reactions. We Men (21) Women (12) Men (5) Women (12) Age ( Postprandial lipemia in the normotriglyceridemic obese B Guerci et al found no difference between men and women in obese and control groups for any of the postprandial parameters studied (Table 3) . Therefore, the data for men and women may be pooled.
Postprandial triglyceride responses (Figure 1
mmolal, NS), whereas they remained elevated in the obese group (1.22 AE 0.45 vs 0.93AE 0.22 mmolal, P`0.01) and signi®cantly higher than in controls (P`0.05). There were no signi®cant differences in the chylomicron TG of the two groups. The AUC of non chylomicron TG was, however, signi®cantly greater in obese patients than in controls (512AE 135 vs 429AE 141 mmolal min, P`0.01; Figure 1 ). The TG in the non chylomicron subfraction remained signi®-cantly higher in obese subjects than in controls at T8 (0.91 AE 0.33 vs 0.67AE 0.26 mmolal, P`0.01). The plasma total cholesterol and apo B of the controls and obese were not signi®cantly different and did not change signi®cantly during the OFLT (data not shown).
The incremental AUC for triglycerides in plasma (obese: 259AE 104 mmolal min, and controls: 292AE 187 mmolal min), chylomicron (obese: 109AE 52 mmola l min; and controls: 147 AE 73 mmolal min) and non chylomicron (obese: 108AE 66 mmolal min; and controls: 93 AE 108 mmolal min) fractions did not differ between controls and obese patients.
Postprandial retinyl palmitate responses (Figure 2) . Figure 2 shows the curves for retinyl palmitate in the plasma and subfractions for the two groups. We found no difference in the AUC chylomicron RP of the two groups. The AUCs for plasma RP and non chylomicron RP were signi®cant higher in controls than in obese (301AE 153 vs 217AE 92 mgal min; P`0.05; and Postprandial lipemia in the normotriglyceridemic obese B Guerci et al 157AE 88 vs 103 AE 55 mgal min, P`0.05, respectively). The RP concentrations of all fractions in the two groups were not different at T8. The AUCs of TG and retinyl palmitate were closely correlated in the plasma (r 0.51, P`0.0001) and chylomicron fraction (r 0.55, P`0.0001).
The same trend in the TG and RP differences (AUCs and late time points) between controls and obese patients was observed when men and women were analyzed separately, but it was more pronounced for women than for men (Table 3) .
Postprandial free fatty acids (FFA) and insulin responses. The fasting free fatty acid concentrations at T0 in the obese and control subjects were not different. In the postprandial state, FFA decreased slightly and non signi®cantly 2 h after the test meal to the same extent in both groups (Figure 3) . The plasma FFA concentrations in controls increased and then returned to close to fasting values at T8 (0.74 AE 0.20 vs 0.59AE 0.26 mmolal, P`0.01). The plasma FFA concentrations in obese patients remained stable from T4 to T6, with FFA levels at T8 (0.89AE 0.21 mmolal) which were signi®cantly higher than the fasting values (0.58AE 0.16 mmolal, P`0.0001), or the FFA levels in the control group (0.89 AE 0.21 vs 0.74 AE 0.20 mmolal, P`0.05). The AUCs for FFA for the two groups were not signi®-cantly different (423AE 136 vs 375AE 64 mmolal min, NS).
The plasma insulin levels at T0 were signi®cantly higher in the obese patients (76.7AE 25.7 pmolal) than in controls (39.6 AE 19.5 pmolal, P`0.0001). The post OFLT plasma insulin levels increased signi®cantly in both groups, and returned below baseline at T8. The AUCs for plasma insulin were signi®cantly greater in obese patients (41,945AE 14,810 pmolal min) than in controls (20,461AE 6274 pmolal min, P`0.0001).
Correlation coef®cients
Univariate analyses were carried out for the postprandial lipid parametes which were signi®cantly different between obese and controls. Table 4 shows simple correlation coef®cients between non chylomicron fraction metabolism during the postprandial period (as re¯ected by AUC-TG or ÀRP), and clinical, anthropometric, lipidic and insulin resistance parameters. The AUC of the non chylomicron TG was highly correlated with the log plasma triglyceride concentration at baseline. It was also positively correlated with age, BMI, waist circumference, log leptin, total and LDL-cholesterol, apo B, log plasma insulin at t 120min (OGTT) and log HOMA, but negatively with HDL 2-cholesterol. By contrast, the AUC of non chylomicron RP displayed a very weak negative correlation with BMI and a positive correlation with total cholesterol. Finally, the log AUC plasma RP was not correlated with any of the parameters.
Stepwise regression analysis
Two models of multivariate analysis were developed by stepwise regression (Table 5 ). Analyses are shown for the overall independent variables (model 1) and Postprandial lipemia in the normotriglyceridemic obese B Guerci et al for the clinical characteristics of obesity and insulin resistance (model 2). Analysis of covariance was also performed, leading to exclusion of waist circumference, total cholesterol and LDL cholesterol from the stepwise regression analysis, because these variables were highly statistically correlated (r b 0.85). Plasma TG at baseline, age, BMI, log HOMA, HDL 2, apo B, log leptin and log plasma insulin t 120min (OGTT) are the independent variables in model 1. Plasma TG at baseline predicted 50% and age 11% of the variance of the log AUC non chylomicron TG. Since plasma triglycerides are closely correlated with postprandial lipemia, we excluded plasma triglyceride, apo B and HDL 2 at baseline from model 2. Log HOMA and age both signi®cantly predicted the AUC non chylomicron TG, and accounted for 23% (log HOMA) and 12% (age) of the variance of log AUC non chylomicron TG.
When subjects were matched for age and sex, there was no difference for physical activity between the two groups. Fourteen obese (®ve men, nine women) and 14 healthy controls (5 men, nine women) were studied. We found that AUC non chylomicron TG was signi®cantly higher in obese patients than in controls (513AE 143 vs 427AE 89 mmolal min, P`0.05) and that the AUCs of plasma and non chylomicron RP were both signi®cantly lower in obese patients (204AE 93 vs 283AE 83 mgal min, and 98 AE 67 vs 155AE 54 mgal min, respectively. P`0.05), con®rm-ing the data for the whole group. The second model of the stepwise regression analysis remained valid for matched groups, indicating that log HOMA signi®-cantly predicted 29% of the variance of the log AUC non chylomicron TG.
Discussion
We have detected abnormalities in the postprandial responses of normotriglyceridemic obese subjects to a fat load challenge, even though these subjects displayed no signi®cant degree of hyperlipemia in the fasted state.
The AUC for chylomicron TG was no greater in the obese than in controls, and the chylomicron TG even tended to be lower at all time-points, indicating adequate lipolytic activity. By contrast, the AUC for non chylomicron TG was signi®cantly greater in the obese than in controls, but the AUC for RP in this same fraction and in plasma were smaller in the obese than in controls. The late time-points of postprandial triglycerides in plasma and non chylomicron fraction were higher in obese patients than in controls. We found no difference between men and women in each group of controls and obese. However, there were too few obese men to rule out a potential statistical difference in postprandial responses between men and women. 
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The triglyceride oral ingestion in different studies ranges from 20 to 120 g of fat. 36 We have not adjusted the fat intake of our OFLT for body surface area, as in other studies. 12, 16, 37 Women were therefore presumably given much more fat per body surface area than were men, which may explain why their postprandial responses did not differ from those of men. However, this relative fat intake is close to the lower limit of 50 gabody surface area given in many other studies, 6, 11 suggesting that women did not exceed their postprandial TG-rich lipoproteins clearance capabilities. 38 In contrast, the obese patients had a relatively low dose of the test meal per unit of body surface area, but there were postprandial differences between obese patients and controls that would probably be more marked if we had given fat intake adjusted for body surface area. This may indicate the importance of standardizing the fat test, without adjusting for any clinical or biological parameters. 39 Obesity has detrimental effects on the metabolic pro®le 7 and several studies have evaluated the impact of obesity on postprandial lipid responses. 9, 12, 17 In contrast to our results, two studies reported that the total area under the triglyceride curve and peak plasma triglyceride concentrations were signi®cantly higher in obese patients. 9, 17 However, they studied massively obese individuals, with average BMIs of 38.3 and 44 kgam 2 , and signi®cantly higher fasting plasma TG levels than the lean control subjects.
Our ®rst model of stepwise regression analysis demonstrates that fasting plasma triglycerides and age are correlated with the AUC for non chylomicron TG and explains 50% (TG) and 11% (age) of the variance of this parameter. The correlation between fasting TG and the AUC for non chylomicron TG was expected, since the incremental AUCs for this fraction in the groups were not different. 40 This result is consistent with the previously described association between fasting TG and postprandial lipemia response. 5, 17, 21 This study is the ®rst, to our knowledge, which compares healthy controls and obese patients with fasting triglyceride levels within the normal range, and not signi®cantly different in the two groups. Thus, the fasting triglyceride level appears to be a rather poor parameter for discriminating between controls and obese patients with altered postprandial lipemia in routine clinical practice. This is in accordance with those reported by Schrezenmeir et al, 15 who demonstrated that the plasma fasting TG level is very speci®c, but rather insensitive (47%) for predicting postprandial lipemia responses. Studies on the size and composition of fasting VLDL subfractions and their relationship with postprandial lipemia could be more informative.
The chylomicron and non chylomicron fractions provide interesting informations. First, there are no differences between the groups for TG and RP in the chylomicron fraction. These data suggest that the metabolism of chylomicron was not altered in our obese population with normal glucose tolerance and normal fasting lipid parameters in the early stages of insulin resistance. This has recently been suggested by Mekki et al, 12 who found no alteration of triglycerides concentrations in apo B48 TRLs in gynoid normolipidemic obese women.
The second ®nding is the discrepancy between the TG and RP in the non chylomicron fraction; the RP concentrations were signi®cantly lower and the TG concentrations were signi®cantly higher in this fraction in normolipidemic obese patients than in controls. Although RP is a marker of intestinal TG-rich lipoproteins, several authors have detected small amounts of RP in lipoproteins of hepatic origin. 41, 42 This RP fraction is of greater signi®cance at later postprandial times (above 8 h), suggesting that it is derived from the transfer between plasma lipoproteins. 41, 42 Therefore, other authors consider this transfer to be quantitatively nonsigni®cant. 43 ± 45 Under our conditions (last sample time 8 h), the concentration of RP in the non chylomicron fraction, which contained TRL (chylomicron remnants, VLDL, VLDL remnants), can be considered to be predominantly derived from the remnants of chylomicrons.
The postprandial non chylomicron RP response (AUC) was lower for obese subjects than for the controls suggesting that the clearance of chylomicron remnants was normal or even increased in obese patients. In contrast, the levels of triglycerides in the non chylomicron fraction are greater for obese subjects than for controls. As the lipolytic response for the chylomicron and chylomicron remnants is considered to be normal, the increased TG in the non chylomicron fraction suggests increased TGs from the liver.
We therefore propose that TG from endogenous TG-rich lipoproteins, presumably VLDL particles, accounts for most of the postprandial increase in TG in the non chylomicron fraction in the normolipidemic obese group. This has been evoked by others for hypertriglyceridemic obeses, 9,10 the offspring of parents with early coronary artery disease, 46 and in normolipidemic men with coronary heart disease.
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More recently, Vansant et al 17 reported higher plasma TG and lower plasma RP concentrations in obese normolipidemic women during postprandial lipemia, suggesting that a signi®cant portion of the postprandial TG response is due to endogenous hepatic lipoproteins. However, lipid subfractions were not analyzed and the postulate was not con®rmed.
The mechanism responsible for a postprandial increase in the concentration of endogenous hepatic lipoproteins is not clear. Decreased catabolism andaor increased hepatic synthesis of TG-rich lipoproteins could contribute to this phenomenon. Postprandial VLDL clearance might be delayed because of competition for lipoprotein lipase (LPL) between chylomicrons and VLDL. The LPL on the surface of capillary endothelial cells acts preferentially on large chylomicrons, thereby causing an increase in the residence time of VLDL in the blood. 47 Postprandial lipemia in the normotriglyceridemic obese B Guerci et al Another explanation could be the synthesis of TG triggered by an increased¯ux of FFAs to the liver, supplying it with substrates which stimulate hepatic VLDL-TG secretion. Our normolipidemic obese and control subjects showed no signi®cant differences in postabsorptive and postprandial FFA concentrations during the ®rst 6 h, con®rming the data of Binnert et al. 48 Only the FFA levels were signi®cantly higher in the obese group than in the controls at T8. These higher late postprandial concentrations could lead, at least in part, to increased hepatic synthesis and secretion of VLDL particles in the postprandial state, as suggested by Couillard et al, 10 for subjects with high visceral adipose tissue. The lipolysis of stored triglycerides is poorly inhibited by insulin in insulin resistance, resulting in an increased¯ux of FFAs to the liver, 49 ± 52 as occurred at the later postprandial times in the obese group. The hydrolysis of chylomicrons by LPL may also contribute to the increased¯ux of FFA to the liver in the postprandial state, as demonstrated by Frayn. 53 Finally, an increase in endogenous hepatic lipoprotein production could occur in insulin resistance because the hepatic VLDL production is poorly inhibited by insulin in this situation, whereas the clearance of endogenous lipoproteins may not yet be altered by insulin resistance. It has been recently shown that acute hyperinsulinemia does not suppress hepatic VLDL production in obese subjects, 54 or in type 2 diabetic patients. 55 This may also contribute to the postprandial increase in TG in the non chylomicron fraction.
In accordance with the role of insulin resistance in postprandial lipemia, our second statistical model of stepwise regression showed that HOMA predicted 23% of the variation in the AUC for non chylomicron TG. We found similar results when obese patients were matched with controls for sex and age, suggesting that the insulin resistance has an impact on altered postprandial lipemia, independently of other parameters known to in¯uence the postprandial state, such as age and fasting lipid levels. 56 A previous study demonstrated the role of insulin resistance in altered postprandial lipemia, but the authors did not analyze obesity parameters and insulin resistance separately. 15 Another study on obese women has recently reported that insulin resistance is an independent determinant of postprandial hypertriglyceridemia, but without analyzing subfractions of triglyceride-rich lipoproteins. 17 We found no relationship between parameters related to obesity (BMI, waist-to-hip ratio and leptin levels) and any parameters of the postprandial lipemia. This result suggests that obesity per se has little in¯uence on postprandial lipemia compared with insulin resistance. This is in accordance with studies which found no in¯uence of body fatness (measured on simple parameters such as BMI or waist-to-hip ratio) on postprandial lipemia. 17 However, when the fat distribution was more precisely studied, some authors found that subjects with increased abdominal fat distribution, and therefore potentially more insulin resistance, 14 had altered postprandial lipemia. 10, 17, 57 In conclusion, we have made a special effort to recruit android obese patients with a fasting TG in the normal range and not different from the fasting TG of lean controls. These obese patients had an abnormal postprandial lipemia response, indicated by a signi®-cantly greater TG in the non chylomicron subfraction than in controls. These potentially atherogenic alterations may be partly due to postprandial changes in endogenous lipoproteins as a consequence of insulin resistance. Hence, the fasting plasma TG is not as informative in the early stages of insulin resistance caused by obesity as in other diseases, highlighting the usefulness of oral fat load tests for unmasking abnormalities of lipid metabolism.
